Build Bond Innovation ETF (BFIX)

The problem is that they are losing money on a grand scale and therefore have no money to repurchase shares for - not a credible proposition.

I think it's done . Waiting for several announcements all at once IMPO 👀

Feels like Lazerson has abandoned the ship…

The MHRA is explaining what CTBVEAG does and does not do. They are saying that CTBVEAG does not advise on approvability, licensing requirements or regulatory outcomes. So even if data from a trial discussed by CTBVEAG later ends up being used in an MAA, that does not mean CTBVEAG was giving an opini

Any communication I suppose is better than nothing. They certainly go long periods of time with zero communication at all. But there has been nothing substantial in a very long time. More shares and declining revenue can’t be masked by a few posts. There is no leadership and no talk of progress at a

The two sets of people

1) Those that hold AXXA
and
2) Are IPO worthy investors

probably don't overlap.

Just looking for some honesty - no matter what happens or RGL does or talks about, it's the greatest thing for RDGL. Price goes down -great. We miss a deadline - great. It takes years - great. We do EFS - great. We do.............- great.

That's all

I'm wondering why they have yet to put up Mr. LeMaitre's bio or background as they have for all others I see:

https://www.optica.org/events/industry_events/2026/global_photonics_economic_forum/speakers/yves_lemaitre/

I don’t need AI for what I do, I need efficiency and reliability. All AI we have tested has been horribly inconsistent and developers/consultants just say it’s where AI is at right now. Similar to your posts - they have been all over the board due to lack of understanding of the AI output. Decisions

On what catalyst?

So it's "the unknown" that is holding back the share price?

Good to know.

A clearer timeline, like a couple of years?

There is that 20,000,000 shares



The Company is continuing to review new strategic mineral project opportunities.
Placement
The Company completed a private placement to sophisticated investors and existing key shareholders to
raise $600,000 (befor

Yes it is or so it seems.
https://www.marketscreener.com/insider/LEONARD-TOBOROFF-A04VUC/

Scotiabank lowered the firm's price target on Wix.com to $90 from $110 and keeps an Outperform rating on the shares.

There's only 600,000 shares between the stock and .04 😀

Manipulation, you mean TP and his buddies 😜

I’ve been questioning that for five years. I just don’t see how ST3 could possibly screw up again with the companies he’s working with. That would be the end of him.

But decades late. Timing is everything. Competitor is much further along in human trials, etc. C'est la vie

.0015s up after another 8M+ buy at .0014 took out the walked down ask from manipulators / bashers

Now 20M+ bid at .0013 left behind

INHD, over $9

At least I am in the green now on ETU.

SOAR bottom

Most of the other biotech speculating knuckleheads have scurried off. Maybe they learned something. Hopefully.

Everything I read in his posts before I ignored him showed a failed track record. Many lose out on runs because of him.

https://www.accessnewswire.com/newsroom/en/blockchain-and-cryptocurrency/auri-announces-new-ceo-and-new-business-direction-1173901